Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes

A. Nazha; K. Al-Issa; B. K. Hamilton; T. Radivoyevitch; A. T. Gerds; S. Mukherjee; V. Adema; A. Zarzour; N. Abuhadra; B. J. Patel; C. M. Hirsch; A. Advani; B. Przychodzen; H. E. Carraway; J. P. Maciejewski; M. A. Sekeres

Article

Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes

Leukemia

DOI: 10.1038/leu.2017.266

67Citations

43Readers

Get full text

Cite

CITATION STYLE

APA

Nazha, A., Al-Issa, K., Hamilton, B. K., Radivoyevitch, T., Gerds, A. T., Mukherjee, S., … Sekeres, M. A. (2017). Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes. Leukemia. Nature Publishing Group. https://doi.org/10.1038/leu.2017.266

Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes

Cite

Register to see more suggestions